Philadelphia-positive (Ph+) cells, expressing active tyrosine kinase p210 or p185 (oncoproteins, products of bcr/abl gene), are involved in chronic myeloid leukemia (CML) pathogenesis. Here, EIF3A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.